Dundon, Jondrex G.
HRN: 25-13-28 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/26/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/26/2025
05/06/2025
IV
50 Mg
Q 8 Hours
Intestinal Amoebiasis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes